Phạm TL, Lê HM, Phạm VH, et al. RESULT OF PEMBROLIZUMAB PLUS CHEMOTHERAPY IN THE FIRST-LINE THERAPY FOR DISTANT METASTATIC NON-SMALL-CELL LUNG CANCER WITH PD-L1 ≥1%, EGFR(-), ALK(-) AND ROS1(-). JPMP175. 2024;(37):13. doi:10.59354/ydth175.2024.240